Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Zeft

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The New England Journal of Medicine|May 17, 2018
Canakinumab for the Treatment of Autoinflammatory Recurrent Fever SyndromesFabrizio De Benedetti, Marco Gattorno, Jordi Anton, et al.
The Journal of Rheumatology|August 1, 2024
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III StudyHermine I Brunner, César Pacheco-Tena, Ingrid Louw, et al.
The Journal of Rheumatology|August 4, 2012
Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisionsKimberly Morishita, Jaime Guzman, Peter Chira, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The New England Journal of Medicine|May 17, 2018
Canakinumab for the Treatment of Autoinflammatory Recurrent Fever SyndromesFabrizio De Benedetti, Marco Gattorno, Jordi Anton, et al.
The Journal of Rheumatology|August 1, 2024
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III StudyHermine I Brunner, César Pacheco-Tena, Ingrid Louw, et al.
The Journal of Rheumatology|August 4, 2012
Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisionsKimberly Morishita, Jaime Guzman, Peter Chira, et al.
Pageof 3